Pathogenic perspectives for the role of inflammation in diabetic nephropathy.
about
Pentoxifylline for diabetic kidney diseaseThe potential utilizations of hydrogen as a promising therapeutic strategy against ocular diseasesToll-like receptor activation: from renal inflammation to fibrosisBiomarkers of Renal Disease and Progression in Patients with DiabetesRole of T cells in type 2 diabetic nephropathyInflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targetsDiabetic kidney disease: from physiology to therapeuticsAntagonism of the Prokineticin System Prevents and Reverses Allodynia and Inflammation in a Mouse Model of DiabetesCommon variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians.Study of Neutrophil-lymphocyte Ratio as Novel Marker for Diabetic Nephropathy in Type 2 Diabetes.Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes.Proteomic discovery of diabetic nephropathy biomarkers.A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathyTNF-α and microalbuminuria in patients with type 2 diabetes mellitus.Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammationMultiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress.The identification of gene expression profiles associated with progression of human diabetic neuropathyDeletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat).Deletion of UNC5B in Kidney Epithelium Exacerbates Diabetic Nephropathy in MiceInduction of hemeoxygenase-1 reduces renal oxidative stress and inflammation in diabetic spontaneously hypertensive rats.Therapeutic potential of digitoflavone on diabetic nephropathy: nuclear factor erythroid 2-related factor 2-dependent anti-oxidant and anti-inflammatory effect.Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats.Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathyHistone acetyltransferase PCAF regulates inflammatory molecules in the development of renal injuryRole of Toll-like receptors in diabetic renal lesions in a miniature pig model.Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy.Naringin Alleviates Diabetic Kidney Disease through Inhibiting Oxidative Stress and Inflammatory ReactionDiabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis.Use of Hydrogen as a Novel Therapeutic Strategy Against Photoreceptor Degeneration in Retinitis Pigmentosa Patients.Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney diseaseThe relationship between neutrophil-to-lymphocyte ratio and albuminuria in type 2 diabetic patients: a pilot studyImmune and inflammatory role in renal disease.Maternal nutrient restriction during early fetal kidney development attenuates the renal innate inflammatory response in obese young adult offspring.Association of NFKB1 gene polymorphism (rs28362491) with levels of inflammatory biomarkers and susceptibility to diabetic nephropathy in Asian IndiansSitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animalsRelationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.Antifibrotic treatment and other new strategies for improving renal outcomesReno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.Role of mindin in diabetic nephropathy.
P2860
Q24203643-90CB95E6-0D2B-414E-BDF7-1B9DE9095652Q26747426-703425C6-8874-4077-BA0D-8A43DEE84732Q26796639-0EB3CD17-4470-4EC8-A3A1-776131E1CB0EQ26799505-F6F26D2C-CD5F-4696-A745-C9925A49F5D1Q26849691-D7124972-1326-4B52-B63B-D0528167F51BQ26866480-37139B2C-4942-4A14-BD01-50758EFDBFB5Q27021392-7F02FE08-08B0-43F3-A722-7B9E881FCFA5Q28552033-04E2EED0-53C8-4EA3-93A4-D429F2AB9477Q33428547-6F4A6A17-B660-412F-814C-B9372C0D3801Q33697462-80E969AC-8944-4DF1-B247-09C9B32919FBQ33773287-B55334D8-6108-4595-9227-422EC3F29AAEQ34330236-8589BC30-1AEF-4ED7-9164-B2D511AD5A08Q34549867-8D6333AA-2458-4C5F-BBCD-C6E6327E6898Q34838338-5E02AC94-558E-4455-A2B4-9F993B94D42AQ35070137-BACB2DFA-1C24-4934-A54C-84944F7C6E1DQ35126070-E64D04F6-2FC4-4E37-8839-BA75596CE8ACQ35540055-C6AA69CC-722A-4CBC-9904-4A61456535FFQ35543421-9904FB1F-3C41-46BB-B234-799520670E9FQ35607330-229B64D1-4E44-48F0-BD4E-8E0D50E31EABQ35638934-0706A114-AE82-42FE-8DE2-46C1388C677BQ35821566-0538EFF9-04A1-4D2D-ABB7-5494E8CCFF45Q35884405-9BCA8A4B-36D9-4926-AD4C-63F970DF341CQ35924532-2E3CD857-29C5-4CF4-9674-C2F5AD43BC00Q36117573-5C6B1709-6097-4FC8-BB18-58275369991DQ36213039-6B73A509-AE5E-4077-B9D7-07A179BBB102Q36268119-0EBC598C-D2B4-4770-8067-2F7E06A9F4D0Q36312635-8CEAB17A-D681-41F5-AD0A-21F034A4E44FQ36331862-5212F251-3860-4114-80EE-682972455E3EQ36589609-63AF21E1-C21E-4E39-9153-D2CE5AF07392Q36672903-FDD1E147-3467-457C-804D-6B162B23E724Q36788430-489D5F4C-1803-4EAE-BB56-A997B2D074CFQ36958293-521BD0F0-B611-4A62-8A0C-FA2F5FCE77B5Q37243199-093E2084-96F9-4C8F-90DE-DE591640220FQ37430665-72DD0754-5F97-41F2-B3B8-C4364C01C64CQ37657509-92DB9D1F-65D3-4141-871F-FAE8F287D3DDQ37725539-4534B452-08BF-46E8-9FC5-5F6D3FBB3D52Q37780781-A5535A3A-7B8F-4D51-A5AE-192CC7D31F76Q37887401-573F3C70-3C86-4225-A091-4A90CDAEE3B7Q37960812-6E5FBDF5-8F21-4F1D-AC0A-DE63E7BD7A60Q37974895-5E491834-EA78-4897-8B0E-1E69C14A65F2
P2860
Pathogenic perspectives for the role of inflammation in diabetic nephropathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathogenic perspectives for the role of inflammation in diabetic nephropathy.
@en
Pathogenic perspectives for the role of inflammation in diabetic nephropathy.
@nl
type
label
Pathogenic perspectives for the role of inflammation in diabetic nephropathy.
@en
Pathogenic perspectives for the role of inflammation in diabetic nephropathy.
@nl
prefLabel
Pathogenic perspectives for the role of inflammation in diabetic nephropathy.
@en
Pathogenic perspectives for the role of inflammation in diabetic nephropathy.
@nl
P2093
P356
P1433
P1476
Pathogenic perspectives for the role of inflammation in diabetic nephropathy
@en
P2093
Antonio Rivero
Carmen Mora
Havidian Herrera
Javier García
Mercedes Muros
P304
P356
10.1042/CS20080394
P407
P577
2009-03-01T00:00:00Z